catx: the cashflow

MyFinsight

For the quarter ending 2025-09-30.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Cash Flow	2025-09-30	2025-06-30
Net cash provided by financing activities	10,318	10,105
Net (decrease) increase in cash, cash equivalents and restricted cash	-34,818	-32,731
Cash and cash equivalents at beginning of period	61,580	-
Cash and cash equivalents at end of period	26,762	-

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

For the quarter ending 2025-09-30.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Cash Flow	2025-09-30	2025-06-30
Net cash provided by financing activities	10,318	10,105
Net (decrease) increase in cash, cash equivalents and restricted cash	-34,818	-32,731
Cash and cash equivalents at beginning of period	61,580	-
Cash and cash equivalents at end of period	26,762	-

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Perspective Therapeutics, Inc. (CATX)